Eventually, the population of patients who underwent long-term active anti-VEGF treatment without experiencing blindness markedly increased in our study population despite the fact that there is only a slight increase in the number of newly diagnosed neovascular AMD cases over time. Here, VEGFA is linked to Blindness.